Related Experiment Video
Updated: Dec 23, 2025
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Architect i2000 SR has improved turnaround time for infectious disease serology testing over Vitros ECiQ
Cindy Cheng1, Jocelyn R Hauser1, Caitlin Otto2
1Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center.
Background:
Vitros ECiQ and Architect i2000 SR are two automated instruments used to detect serology biomarkers of hepatitis A, B and C viruses, and HIV infections. We compared performance of the Architect to the Vitro EciQ after implementation at our institution.
Methods:
A retrospective review was performed to compare patient samples tested on the Vitros ECiQ or Architect for hepatitis and HIV serological assays. The positivity rate, frequency of equivocal results, turnaround times (TAT), and hands-on time (HOT) were analyzed.
Results:
There was no statistical difference in the positivity rate between the two instruments, with the exception of two assays. An increase in equivocal results was observed for the Architect (0.2% vs 0.5%). Notably, the TAT for the Architect i2000 was shorter for all except one assay (31.6 vs 33.7 hours) and demonstrated improved workflow.
Conclusions:
Overall, both instruments performed comparably. Architect had shorter TAT over Vitros.
